Concepedia

Richard Oblad

RO

Statistics

Publications

4

Citations

73

H-Index

4

Active since

2016

Affiliations

Brigham Young University(Current)

Richard Oblad is an author at Brigham Young University specializing in cancer pharmacology, pharmacology, and combination therapy.

ORCID

Publications per year

2016–2020

4

Publications

4

Gluten cross-contact from common food practices and preparations

Katharine Parsons, Lindsay Brown, Hannah Clark et al. · Clinical Nutrition · 2020 · 21 citations

, , +12

Resveratrol inhibits plasma membrane Ca 2+ -ATPase inducing an increase in cytoplasmic calcium

Joshua Allen Peterson, Richard Oblad, Jeffrey Chad Mecham et al. · Biochemistry and Biophysics Reports · 2016 · 18 citations · Full text

, , +13

Application of Mixture Design Response Surface Methodology for Combination Chemotherapy in PC-3 Human Prostate Cancer Cells

Richard Oblad, Hayden Doughty, John Lawson et al. · Molecular Pharmacology · 2018 · 17 citations · Full text

, , +14

γ-Tocotrienol and α-Tocopherol Ether Acetate Enhance Docetaxel Activity in Drug-Resistant Prostate Cancer Cells

Spencer Asay, Andrew Graham, Sydney Hollingsworth et al. · Molecules · 2020 · 17 citations · Full text

, , +15

1–4 of 4